1. Combined multiagent chemotherapy and radiotherapy is associated with improved survival compared to chemotherapy alone in patients with non-operatively managed stage II-III pancreatic adenocarcinoma. (2021) Authors: Ocuin, L.M.; Sugumar, K.; Hue, J.J.; Hardacre, J.M.; Ammori, J.B.; Rothermel, L.D.; Dorth, J.; Saltzman, J.; Winter, J.M. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma. (2022) Authors: Sugumar, K.; Hue, J.; Hardacre, J.; Ammori, J.; Rothermel, L.; Dorth, J.; Saltzman, J.; Mohamed, A.; Selfridge, J.; Bajor, D.; Winter, J.; Ocuin, L. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗